共 184 条
[1]
Kadri SS(2017)Estimating ten-year trends in septic shock incidence and mortality in United States academic medical centers using clinical data Chest 151 278-285
[2]
Rhee C(2014)Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions Lancet Infect Dis 14 498-509
[3]
Strich JR(2012)Continuous beta-lactam infusion in critically ill patients: the clinical evidence Ann Intensive Care 2 37-18
[4]
Morales MK(2007)Continuous infusion of β-lactam antibiotics in severe infections: a review of its role Int J Antimicrob Agents 30 11-377
[5]
Hohmann S(2017)Surviving sepsis campaign: international guidelines for Management of Sepsis and Septic Shock: 2016 Intensive Care Med 43 304-691
[6]
Menchaca J(2011)Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials BMC Infect Dis 11 181-120
[7]
Roberts JA(2018)The Japanese clinical practice guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016) J Intensive Care 6 7-W94
[8]
Abdul-Aziz MH(2016)Continuous versus intermittent β-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials Am J Respir Crit Care Med 194 681-810
[9]
Lipman J(2018)Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials Lancet Infect Dis 18 108-394
[10]
Mouton JW(2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration Ann Intern Med 151 W65-188